Mount Sinai Health System has agreed to halt all gender‑affirming medical services for minors, a decision reached after negotiations with the Trump administration’s Department of Justice. The settlement follows a federal lawsuit alleging that the hospital’s pediatric endocrinology program violated state and federal laws by providing hormone therapy and puberty blockers to transgender youth without proper oversight. In the agreement, Mount Sinai will discontinue these treatments, implement new compliance protocols and submit to ongoing monitoring, while the DOJ will drop its claims of wrongdoing. The move marks a significant shift in the provision of transgender health care in New York and signals a broader federal push to restrict gender‑affirming services for children across the country.
Mount Sinai ends pediatric gender-affirming care in agreement with Trump DOJ New York Daily News
